Cerillo Alfredo Giuseppe, Mariani Massimiliano, Glauber Mattia, Berti Sergio
J Heart Valve Dis. 2014 Jan;23(1):138-41.
Transcatheter valve-in-valve implantation is an emerging treatment option for high-risk patients with failing mitral bioprostheses. The presence of a paravalvular leak is considered a contraindication to this procedure that would leave the patient with significant residual regurgitation. The case is described of a patient with a severely degenerated 29 mm Carpentier-Edwards mitral bioprosthesis successfully treated by simultaneous transapical transcatheter valve-in-valve implantation and paraprosthetic leak occlusion. The potential advantages of this approach are discussed.
经导管瓣中瓣植入术是治疗二尖瓣生物瓣功能衰竭高危患者的一种新兴治疗选择。瓣周漏的存在被认为是该手术的禁忌证，因为这会使患者残留明显的反流。本文描述了一例患有严重退化的29毫米Carpentier-Edwards二尖瓣生物瓣的患者，通过经心尖同期经导管瓣中瓣植入术和人工瓣膜旁漏封堵术成功得到治疗。文中还讨论了这种方法的潜在优势。
